Lv2
110 积分 2025-12-06 加入
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
24天前
已完结
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
25天前
已完结
First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma
3个月前
已关闭
Targeting the hippo pathway as a potential regulator of immune checkpoints in cancer immunotherapy
3个月前
已完结
Molecular and immune pathobiology of human angiosarcoma
3个月前
已完结
Molecular and immune pathobiology of human angiosarcoma
3个月前
已完结
Regulation of the tumor immune microenvironment by the Hippo Pathway: Implications for cancer immunotherapy
3个月前
已完结
Targeting the hippo pathway as a potential regulator of immune checkpoints in cancer immunotherapy
3个月前
已完结
Translating molecular mechanisms of epithelioid hemangioendothelioma to improve patient outcome
3个月前
已完结
皖公网安备34019202002308
